Eslami SM, Nikfar S, Ghasemi M, Abdollahi M. Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials. J Pharm Pharm Sci [Internet]. 2017 Apr. 11 [cited 2024 Jul. 17];20:81-96. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/28581